Financials
- Market Capitalization 2 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1923 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.30 USD | -1.93% | -4.34% | -14.76% | -18.49% | 2.07 B USD | ||
| 1948 | PHVS Pharvaris N.V. - Ordinary Shares | 30.89 USD | -0.68% | +1.28% | -19.24% | +41.70% | 2.01 B USD | ||
| 1953 | FTRE Fortrea Holdings Inc. - Common Stock | 21.00 USD | +0.77% | -4.55% | +21.95% | +121.99% | 2.00 B USD | ||
| 1961 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.23 USD | -4.88% | -5.56% | -21.00% | -44.93% | 1.97 B USD |
Frequently asked questions about Vera Therapeutics, Inc. Class A Common Stock
What is the Vera Therapeutics, Inc. Class A Common Stock stock price today?
The current price of Vera Therapeutics, Inc. Class A Common Stock (VERA) is 27.72. Over the past 24 hours, the stock has changed by -7.23%. Follow the VERA chart for real-time price dynamics.
What is the stock ticker of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock trades under the ticker VERA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vera Therapeutics, Inc. Class A Common Stock stock going up?
VERA has changed by -7.54% over the last week, -21.05% over the last month, and -6.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 2 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vera Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, Vera Therapeutics, Inc. Class A Common Stock reported earnings of -1.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vera Therapeutics, Inc. Class A Common Stock revenue for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported quarterly revenue of -483 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vera Therapeutics, Inc. Class A Common Stock net income for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported net income of -109.47 M for the last quarter. The previous quarter showed -121.03 M, which means net income changed by +9.55%.
How many employees does Vera Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, Vera Therapeutics, Inc. Class A Common Stock has 361 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vera Therapeutics, Inc. Class A Common Stock EBITDA?
Vera Therapeutics, Inc. Class A Common Stock EBITDA is -112.84 M, and its EBITDA margin is 23.36 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vera Therapeutics, Inc. Class A Common Stock stock?
You can buy Vera Therapeutics, Inc. Class A Common Stock (VERA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vera Therapeutics, Inc. Class A Common Stock stock?
Investing in Vera Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VERA chart and related analysis on metatrader.com as part of your research.